NYSE:HIMS   Hims & Hers Health, Inc.
HIMS - the recent double beat and guidance raise has not helped out this stock. There is a gap fill dating back to November of 2022 with hardly any strong support zones in sight. The death cross which just occurred should add further downward pressure to this already beaten up stock. I will turn long on HIMS once the first level of support is reached (around $6.20). I will add on the way down as the stock approaches the gap fill. The increased guidance and double beat proves this may be a long-term winner, however, in the short-term there is more room to fall.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。